Contrary to other biomarkers, which only become elevated once the glomerular filtration rate (GFR) decreases, syndecan-1 increases even in the presence of a continuous glycocalyx damage, as it is the “subclinical” AKI [7]. This evidence concerns the gene SDC1 and acute kidney injury.